Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should we try the antiinflammatory natural product, celastrol, for COVID-19?
Habtemariam S, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Izadi M, Sureda A, Nabavi SM. Habtemariam S, et al. Among authors: cismaru ca. Phytother Res. 2020 Jun;34(6):1189-1190. doi: 10.1002/ptr.6711. Epub 2020 Apr 29. Phytother Res. 2020. PMID: 32347602 Free PMC article. No abstract available.
Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2.
Habtemariam S, Nabavi SF, Ghavami S, Cismaru CA, Berindan-Neagoe I, Nabavi SM. Habtemariam S, et al. Among authors: cismaru ca. Pharmacol Res. 2020 Jul;157:104853. doi: 10.1016/j.phrs.2020.104853. Epub 2020 Apr 30. Pharmacol Res. 2020. PMID: 32360584 Free PMC article. No abstract available.
Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2.
Nabavi SF, Habtemariam S, Clementi E, Berindan-Neagoe I, Cismaru CA, Rasekhian M, Banach M, Izadi M, Bagheri M, Bagheri MS, Nabavi SM. Nabavi SF, et al. Among authors: cismaru ca. Arch Med Sci. 2020 Apr 14;16(3):519-521. doi: 10.5114/aoms.2020.94504. eCollection 2020. Arch Med Sci. 2020. PMID: 32399097 Free PMC article. No abstract available.
Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID-19: Shoot the messenger!
Habtemariam S, Berindan-Neagoe I, Cismaru CA, Schaafsma D, Nabavi SF, Ghavami S, Banach M, Nabavi SM. Habtemariam S, et al. Among authors: cismaru ca. J Cell Mol Med. 2020 Sep;24(17):10267-10269. doi: 10.1111/jcmm.15652. Epub 2020 Jul 17. J Cell Mol Med. 2020. PMID: 32677763 Free PMC article. No abstract available.
Possible Targets and Therapies of SARS-CoV-2 Infection.
Sarkar K, Sil PC, Nabavi SF, Berindan-Neagoe I, Cismaru CA, Nabavi SM, Habtemariam S. Sarkar K, et al. Among authors: cismaru ca. Mini Rev Med Chem. 2020;20(18):1900-1907. doi: 10.2174/1389557520666200807131855. Mini Rev Med Chem. 2020. PMID: 32767936 Review.
20 results